Sponsored Links
| Triple Therapy Halves Exacerbations In Moderate-to-Severe COPD |
 |
 |
 |
| Medical News - COPD | |||
|
Patients with moderate to severe chronic obstructive pulmonary disease (COPD) can benefit from triple therapy that includes a long-acting β-agonist (LABA), an inhaled corticosteroid (ICS) and an anti-muscarinic agent, according to researchers in Germany. Read more: COPD News From Medical News Today
|